Sulfuric Acid

Sulfuric Acid

SCHEMBL942546

O=S(=O)([O-])O.O=S(=O)([O-])O.O=S(=O)([O-])O.[Al+3]

nearest known ligand 0.80

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CYP51cyp51Acyp51c

The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.80
MEN1 O00255 1/20 0.80
ALDH1A1 P00352 1/20 0.80
KMT2A Q03164 1/20 0.80
CA5A P35218 2/20 0.50
CA5B Q9Y2D0 2/20 0.50
CA2 P00918 2/20 0.42
TDP1 Q9NUW8 2/20 0.42
CA1 P00915 1/20 0.42
NT5E P21589 1/20 0.42
CA4 P22748 1/20 0.42
CA6 P23280 1/20 0.42
CA7 P43166 1/20 0.42
CA9 Q16790 1/20 0.42
TP53 P04637 1/20 0.35
BLM P54132 1/20 0.31
KDM4E B2RXH2 1/20 0.31
LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfuric Acid SCHEMBL729489 0.95 TSHR (0.90) TSHRMEN1ALDH1A1KMT2ACA5A
Sulfuric Acid SCHEMBL17183884 0.95 TSHR (0.73) TSHRMEN1ALDH1A1KMT2ACA5A
Sulfuric Acid SCHEMBL29118215 0.95 TSHR (0.73) TSHRMEN1ALDH1A1KMT2ACA5A
Sulfuric Acid SCHEMBL1774141 0.95 TSHR (0.73) TSHRMEN1ALDH1A1KMT2ACA5A
Sulfuric Acid SCHEMBL9719509 0.95 TSHR (0.73) TSHRMEN1ALDH1A1KMT2ACA5A
Sulfuric Acid SCHEMBL8508840 0.95 TSHR (0.73) TSHRMEN1ALDH1A1KMT2ACA5A
Sulfuric Acid SCHEMBL28184869 0.95 TSHR (0.73) TSHRMEN1ALDH1A1KMT2ACA5A
Sulfuric Acid SCHEMBL17894339 0.91 TSHR (0.67) TSHRMEN1ALDH1A1KMT2ACA5A
Sulfuric Acid SCHEMBL6551102 0.91 TSHR (0.67) TSHRMEN1ALDH1A1KMT2ACA5A
Sulfuric Acid SCHEMBL14956193 0.91 TSHR (0.67) TSHRMEN1ALDH1A1KMT2ACA5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 303 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4709827-A1 WICK AND METHOD FOR TREATING A WICK Schreiber GmbH (DE) 2026-03-18 EP claimed
US-12263464-B2 Method for in-situ synthesis of metal organic frameworks (MOFs), covalent organic frameworks (COFs) and zeolite imidazolate frameworks (ZIFs), and applications thereof DESICCANT ROTORS INTERNATIONAL PRIVATE LIMITED (IN) 2025-04-01 US claimed
CN-115873224-B Catalyst composition for polyester, hydrolysis-resistant polyester film and preparation method 中国石油化工股份有限公司 2025-03-07 CN claimed
CN-222293823-U Water-saving device for alkali decrement printing and dyeing process 浙江台洋纺织科技有限公司 2025-01-03 CN claimed
WO-2024231467-A1 WICK AND METHOD FOR TREATING A WICK SCHREIBER GMBH (DE) 2024-11-14 WO claimed
CN-114207153-B Methods and kits for screening colorectal neoplasms 上海鹍远健康科技有限公司 2024-09-13 CN claimed
US-11837462-B2 Solar spectral wavelength converting material and solar cell comprising same HANWHA TOTAL PETROCHEMICAL CO., LTD. (KR) 2023-12-05 US claimed
US-11824127-B2 Solar cell including aluminum-based solar energy conversion material HANWHA TOTAL PETROCHEMICAL CO., LTD. (KR) 2023-11-21 US claimed
CN-116282432-A Regulator and application thereof in water treatment 珠海市供水有限公司 2023-06-23 CN claimed
CN-116083563-A Fecal intestinal cancer multi-target methylation gene detection reagent and method 上海长岛抗体诊断试剂有限公司 2023-05-09 CN claimed
US-20040265256-A1 Alkaline hair-relaxing in the presence of at least one high molecular weight water-soluble polymer L'OREAL S.A. (FR) 2004-12-30 US claimed
US-20040192640-A1 Use of sucralfate for the treatment of cervical erosion FARMIGEA S.P.A. (IT) 2004-09-30 US claimed
US-6610756-B1 Fireproof SANYO CHECMICAL INDUSTRIES, LTD. (JP) 2003-08-26 US claimed
EP-0433067-B1 A non-specific immunomodulating agent and a process for its production BUEYUEKKOCA EDIP PROF DR (TR) 1995-03-29 EP claimed
EP-0302155-B1 Preparation of a new diosmine derivate ESPANOLA PROD QUIMICOS (ES) 1993-10-27 EP claimed
CN-1065486-A The manufacture method of compound activated aids for synthetic detergent LUZHOU INST OF PRECISION CHEMI (CN) 1992-10-21 CN claimed
EP-0433067-A2 A non-specific immunomodulating agent and a process for its production Büyükkoca, Edip, Prof. Dr. (TR) 1991-06-19 EP claimed
US-4895821-A MOISTURE RESISTANT, EXHAUST SYSTEM REDUCTION OF NITROGEN OXIDES DIDIER-WERKE AG (DE) 1990-01-23 US claimed
US-4894449-A Diosmin octakis (hydrogen sulfate) aluminum complex FABRICA ESPANOLA DE PRODUCTOS QUIMICOS Y FARMACEUTICOS S.A. (FAES) (ES) 1990-01-16 US claimed
US-4289673-A N-METHYLOL REAGENT, ACID CATALYST, AND SELECTED PHOSPHATE SALTS THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) 1981-09-15 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040265256-A1 Alkaline hair-relaxing in the presence of at least one high molecular weight water-soluble polymer KRT18, MYOC, H1-10 TSHR 2009/4885MEN1 1404/4885ALDH1A1 2146/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.